Anchyra Partners LLC initiated a new position in Tesla Inc. (NASDAQ: TSLA) during the most recent reporting period, according to a regulatory filing disclosed on April 27, 2026, adding the electric vehicle and artificial intelligence company to its portfolio at a moment when institutional opinion on TSLA is divided more sharply than at almost any previous point in the stock’s history as the market attempts to value a business that has been publicly repositioned by its CEO as primarily an AI company rather than an automotive one.
Tesla’s stock has been trading in the range of $370 to $400 following the Q1 2026 earnings release on April 22, having pulled back from the initial after-hours surge of approximately 4 percent once the earnings call disclosed that the company’s full-year capital expenditure guidance had been raised to above $25 billion, roughly $5 billion more than previously guided, with management explicitly warning of negative free cash flow for the remainder of the year as it scales Cybercab production, Optimus robot manufacturing, and AI infrastructure simultaneously.
The fundamental picture that Anchyra and other new institutional investors are buying into is genuinely bifurcated: the core automotive business delivered Q1 revenue of $22.39 billion on earnings per share of $0.41, both beating consensus estimates, but vehicle deliveries of 358,023 in Q1 missed expectations and 2025 represented the company’s first ever year of annual revenue decline at the group level, driven by the combination of an ongoing EV price war, softening consumer demand in key markets, and Elon Musk’s public political activities generating consumer boycotts in several major European markets.
The bull case that attracts new institutional entrants like Anchyra centres on Tesla’s autonomous vehicle programme, where paid Robotaxi miles nearly doubled sequentially in Q1 2026 and the Cybercab, Tesla’s purpose-built autonomous vehicle designed without a steering wheel or pedals, entered pilot production at Gigafactory Texas in April, with management guiding for an expansion of unsupervised robotaxi operations beyond Austin into Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas through 2026.
Full Self-Driving subscriptions reached 1.28 million active users in Q1, a metric that management continues to cite as evidence of the software and services revenue model taking shape, even though the absolute revenue contribution from subscriptions remains small relative to the hardware business that still accounts for the overwhelming majority of Tesla’s top line.
Anchyra’s entry comes against a backdrop in which institutional opinion is genuinely polarised rather than merely having a wide range of price targets: 18 of the approximately 41 active analyst recommendations are Buy, 14 are Hold, and 9 are Sell, a distribution that reflects an unusual degree of conviction on both sides and makes Tesla one of the most actively debated large-cap positions in institutional equity management.
The Optimus humanoid robot programme is the other pillar of the long-term bull case that Anchyra and similar investors are underwriting with their new positions, with Tesla’s plans to begin large-scale Optimus factory production in Q2 aiming at a production rate of one million robots per year, an ambition that Wedbush analyst Dan Ives has argued represents the “AI golden era” for the company that will generate revenue in amounts that make the current automotive discussion largely irrelevant to the long-term investment thesis.
Whether Anchyra’s position is sized as a core holding or a tactical bet on the AI transformation narrative ahead of next quarter’s update will determine how much weight should be attached to it as a directional signal, but its arrival as a new institutional investor at approximately current price levels adds to the evidence that sophisticated capital continues to find entry points in TSLA compelling even at valuations that traditional automotive multiple frameworks cannot easily accommodate.
